Stock of Interest

Posted On: September 25, 2023

Stock Report: ARTEMISMED(NSE) 22 Sep 2023

Medicare Services Ltd is engaged in managing and operating multi-specialty hospitals. The hospital provides treatments for Allergy and Immunology, Blood (Haematology), Bones, Muscles and Joints (Orthopaedics), Brain, Spine and Nervous System, Cancer (Oncology), Circulatory (Vascular), Digestive (Gastroenterology), Endocrine, Diabetes And Metabolism, Dermatology, Heart (Cardiology), Infectious Diseases, Kidneys (Renal), Lung (Pulmonary), Mouth, Teeth And Face (Oral And Maxillofacial), Obstetrics And Gynecology, Psychiatry, Rheumatology (Arthritis And Joint Disease), Surgery, and Urology. The group derives revenue primarily from offering healthcare services and has a business presence in India and Outside India.

#xCalData predicts that ARTEMISMED will continue its bullish phase over the next five days and trend within the range of 148 to 168. 

In comparison to the previous month, the price of the stock has experienced an increase of 27.73% indicating a bullish. 

The Stock has doubled once since 30 Mar 2020 and took an average of 0.9 years to double. 

The stock has not shown seasonality trend in the past. 

Reviewing the returns for the past 3 years for the same week, we see the stock has given negative returns in 2 years in the past. 

Majority of the technical ratios trend towards Bullish side of the spectrum. 

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData